Rafael C. Rosell
Advanced in Metastatic Brain Tumor

Rafael C. Rosell

Dr. Rosell Oncology Institute, 
Barcelona, CT, ES 
Advanced in Metastatic Brain Tumor
Dr. Rosell Oncology Institute, 
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Rafael Rosell practices in Barcelona, Spain. Mr. Rosell is rated as an Advanced expert by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Tissue Biopsy, and Adenoidectomy.

His clinical research consists of co-authoring 446 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Metastatic Brain Tumor.

Gender
Male

Locations

Dr. Rosell Oncology Institute, Barcelona, CT 08028, Spain
Other Locations
Badalona, CT, Spain
Cerdanyola Del Valles, CT, Spain
Frias, CL, Spain
Bellaterra, CT, Spain
Department Of Otorhinolaryngology Head And Neck Surgery, Sabadell, CT, Spain
Instituto Oncológico Dr Rosell, 1. 08195 Sant Cugat Del Vallès, Sant Cugat Del Valles, CT 08195, Spain
A Coruna, GA, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Drug
Study Drugs: Aldoxorubicin, Topotecan
Study Phase: Phase 2

445 Total Publications

Concerns about induction of autophagy: à propos of ibrilatazar.
Concerns about induction of autophagy: à propos of ibrilatazar.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rosell's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile